4.6 Article

Total Syntheses of Cyanthiwigins B, F, and G

Journal

CHEMISTRY-A EUROPEAN JOURNAL
Volume 17, Issue 36, Pages 9957-9969

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.201100425

Keywords

asymmetric catalysis; diterpene; natural product; palladium; total synthesis

Funding

  1. King Abdullah University of Science and Technology (KAUST) [KUS-11-006-02]
  2. NIH-NIGMS [R01M080269-01]
  3. Amgen
  4. Abbott
  5. Boehringer Ingelheim
  6. Merck
  7. Bristol-Myers Squibbs
  8. GlaxoSmithKline
  9. Johnson and Johnson
  10. Merck Research Laboratories
  11. Pfizer
  12. Novartis
  13. Roche
  14. Abbott Laboratories
  15. AstraZeneca
  16. Caltech

Ask authors/readers for more resources

A concise and versatile approach toward the preparation of the cyanthiwigin family of cyathane natural products is described. By leveraging a unique double asymmetric catalytic alkylation procedure it is possible to quickly establish two of the most critical stereocenters of the cyanthiwigin framework with high levels of selectivity and expediency. The synthetic route additionally employs both a tandem ring-closing cross-metathesis reaction, and an aldehyde-olefin radical cyclization process, in order to rapidly arrive at the tricyclic cyathane core of the cyanthiwigin molecules. From this unifying intermediate, the preparations of cyanthiwigins B, F, and G are attained swiftly and without the need for protecting groups.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available